THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF;SCHERING CORPORATION
发明人:
CUA, DANIEL J.,KASTELEIN, ROBERT A.,TSAI, VAN T.,CASPI, RACHEL,SILVER, PHYLLIS,LUGER, DROR
申请号：
TW101115664
公开号：
TW201235050A
申请日:
2006.08.31
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.
